Therapy outcomes associated with prescription cannabidiol use at 12 months post-initiation
CONCLUSION: Despite potential benefits of prescription CBD, many patients utilize EHSs in the first 12 months of treatment with minimal changes in concomitant ASM use.PMID:37666204 | DOI:10.1016/j.yebeh.2023.109412
Source: Epilepsy and Behaviour - Category: Neurology Authors: Kayla Johnson Jessica P Barnes Holly Dial Josh DeClercq Leena Choi Nisha B Shah Shilpa Reddy Autumn D Zuckerman Source Type: research
More News: Clinical Trials | Emergency Medicine | Epilepsy | Insurance | Neurology | Pediatrics | Study